DABIGATRAN ETEXILATE

SynDRA canonical compound SYN0019636 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	F2
Mechanism of action	Serine protease inhibitor
Indication	deep vein thrombosis (DVT) \| pulmonary embolism (PE) \| stroke \| systemic embolism
Disease area	hematology \| neurology/psychiatry

All known targets

BIBR-1048
dabigatran etexilate mesilate
pradaxa
dabigatran etexilate mesylate
dabigatran etexilate methanesulfonate
Dabigatran etexilato
Dabigatran etexilate methanesulfonate
BIBR-1048-BS-RS1
BIBR1048
Pradaxa
Prazaxa
Dabigatran etexilate mesylate
XETBXHPXHHOLOE-UHFFFAOYSA-N
CP0128
FT-0660872
ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate methanesulphonate
1-methyl-2-[N-[4-(N-n-hexyloxycarbonylamidino)phenyl]-amino-methyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)-amide mesylate
Dabigatran etexilate mesilate
ethyl N-[(2-{[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate
BIBR-1048 (Dabigatran)
UNII-2E18WX195X
CHEBI:70746
2E18WX195X
cc-72
DSSTox_CID_31470
DSSTox_RID_97355
DSSTox_GSID_57681
SCHEMBL505829
DTXSID4057681
Dabigatran etexilate (USAN/INN)
MolPort-016-633-287
EBD35035
Tox21_113924
BDBM504
dabigatran-etexilate
PRADAXA (DABIGATRAN ETEXILATE)
MLS006010034